Polyunsaturated fatty acids (PUFAs) have been shown to have significant effects on hepatic lipogenic gene expression. The S14 gene has been used as a model to examine the effects of PUFAs on hepatic lipogenic gene expression. In vivo studies showed that feeding rats a high carbohydrate diet containing menhaden oil rapidly (within hours) and signfficantly (250%) attenuates hepatic S14 gene transcription and S14 mRNA abundance. The suppressive effect of menhaden oil was both gene and tissue specific. The effect of PUFAs on expression of the S14 mRNA and a transected S14 fusion gene (i.e., S14CAT4.3) was examined in cultured hepatocytes in the presence of trilodothyronine (T3), insulin, dexamethasone, and albumin under serum-free conditions. Whereas T3 stimulated both S14 mRNA (>40-fold) and S14CAT4.3 (>100-fold), eicosapentaenoic acid (C20:5a3) significantly attenuated (>80%) both S14 mRNA and S14CAT activity in a dosedependent fashion. The effects of C20:5 on hepatocyte gene expression were both gene and fatty acid specflc. Deletion analysis of transfected S14CAT fusion genes indicated that the S14 thyroid hormone response element (at -2.5 to -2.9 kb) was not sensitive to C20:5 control. The cis-linked PUFA response elements were localized to a region within the S14 proxinal promoter (at -80 to -220 bp). This region also contains cis-acting elements that potentiate T3 actVation of S14 gene ranscription. These studies suggest that C20:5 (or its metabolites) regulates factors within the S14 proximal promoter region that are important for T3 activation of S14 gene tanscription.
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Dietary polyunsaturated fatty acids (PUFAs), particularly those rich in 20-and 22 -carbon (w3 and w6) fatty acids, have several unique metabolic effects including suppression of very low density lipoprotein production, reduction of cholesterol synthesis, diminution of blood pressure, and modulation of the growth of certain carcinomas (1) (2) (3) . A particularly intriguing feature of PUFAs is their ability to regulate the expression of several genes involved in lipid metabolism, such as the genes encoding apolipoprotein AI (4) , low density lipoprotein receptors (5), glucose-6-phosphate dehydrogenase (6) , and fatty acid synthase and the S14 protein (7) (8) (9) .
PUFAs suppress the hepatic mRNAs coding for the S14 protein (pI 4.9; 17 kDa) in both adult and weaning rats by inhibiting S14 gene transcription (7) (8) (9) . S14 gene transcription is induced by 3,5,3'-triiodothyronine (T3) (10, 11) , glucocorticoids (12, 13) , retinoic acid (14, 15) , insulin, carbohydrate (16) (17) (18) (19) , and tissue-specific factors (20) and suppressed by factors that elevate hepatic cAMP levels (16) . While the molecular basis for PUFA-mediated inhibition of gene transcription remains unclear, our understanding of the regulation of S14 gene expression makes this an attractive model to
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examine specific aspects of PUFA action at the molecular level.
In this report, the effects of triolein and menhaden oil on the regulation ofhepatic S14 gene expression were examined. (9) . Diets were supplemented (at 10% wt/wt) with either triolein [1,2,3-tri(cis-9-octadecenoyl)-glycerol; >95%; Sigma] or menhaden oil (MaxEPA, Scherer, FL). All diets contained butylated hydroxytoluene at 0.1% wt/wt (9, 21) . Gas chromatographic analysis showed that menhaden oil contained 433.5 mg ofpolyenes perg as w03 fatty acids (347.1 mg/g) and w6 fatty acids (26.6 mg/g). EPA and DHA were present at 160.9 mg/g and 112.4 mg/g, respectively.
RNA Extraction/Transcription. Liver, epididymal fat, and hepatocyte total RNA were isolated (24) and used for measurement of mRNAs coding for S14, 1-actin, and phosphoenolpyruvate carboxykinase (PepCk) by Northern and dotblot analyses (10, 12) . Hepatic nuclei were isolated for run-on gene transcription analysis (17 (18, 26) . This mixture was added directly to each dish. After treatment with the DNA-liposome mixture for 12 hr, medium was replaced with serum-free experimental Williams' E medium.
Hepatocytes were transfected with S14-chloramphenicol acetyltransferase (CAT) fusion genes. S14CAT4.3, S14CAT1.6, and S14CATO.29 have 3' end points at +19 bp and 5' end points at -4315, -1601, and -290 bp, respectively, relative to the 5' end of the rat S14 gene (15, 35) . Transcription of the S14 gene in hepatocytes is driven by thyroid hormone response elements (TREs) located between -2502 and -2900 bp upstream from the 5' end ofthe gene (10, 11, 17 (28) and CAT activity (29) .
RESULTS

Effects of Triolein and Menhaden
Oil on S14 Gene Expression. In rats fed the triolein diet, food ingestion induced S14 mRNA nearly 3-fold (Fig. 1 ). This is due to the HiCHOmediated elevation of S14 gene transcription (17) . In contrast, rats fed the menhaden oil diet showed both a suppressed (>90%6) premeal level of hepatic S14 mRNA and virtually no induction of S14 mRNA after feeding. Menhaden oil abrogates the stimulatory effects of the HiCHO diet on hepatic S14 gene expression.
Knetics of Menhaden Oil Action on Hepatic S14 Gene Expresion. The rapidity of the menhaden oil effect on hepatic S14 gene expression was examined in rats meal-trained on a triolein diet and then switched to a menhaden oil diet. In contrast to the rats maintained on the triolein diet, rats switched to the menhaden oil diet showed a progressive decline in both S14 gene transcription and S14 mRNA (Fig. 2) . A single meal ofmenhaden oil suppressed S14 gene expression by 50%. After 2 and 5 days on the menhaden oil diet, S14 gene expression was suppressed by >75% and >901%, respectively. S14 transcription rates paralleled the decline in S14 mRNA, indicating that the principal site of menhaden oil action was at the level of S14 gene transcription.
Gene Kinetics of menhaden oil inhibition of S14 gene expression. Rats were meal-fed a triolein diet as described in Fig. 1 . Rats were either maintained on the triolein diet or switched to a menhaden oil diet for one, two, or five meals (days). Rats were killed 90 min after food removal. Hepatic RNA and nuclei were isolated for S14 mRNA (o) and transcription (e) analysis. Results are expressed as means ± SE relative to the triolein control. Hepatic S14 mRNA (3.% ± 0.27 units) and transcription rates (52.8 ± 6.1 ppm) in the triolein-fed rats did not vary significantly over the 5-day experiment. Three animals were in each group. Similar results were obtained when rats were killed 5 hr after removal of food.
ence of highly unsaturated fatty acids, like EPA (C20:5C13) and DHA (C22:6w3), in fish oils (21) (22) (23) . Primary hepatocyte cultures were treated with a monounsaturated fatty acid, oleic acid (C18:1w9), or a polyunsaturated fatty acid, C20:5, to determine whether these fatty acids acted directly on hepatocytes to affect gene expression.
The effects of C18:1 and C20:5 on S14 gene expression were assessed in the presence of T3. T3 induced S14 mRNA -40-fold in the absence of fatty acids. Accordingly, hepatocyte monolayers were treated with serum-free medium containing insulin (1 ,uM), dexamethasone (10 nM), and T3 (1 ,uM) in the absence and presence of albumin-bound fatty acids. When compared to control cultures receiving only albumin, C18:1 treatment of hepatocytes only marginally (<20%o) suppressed S14 mRNA levels over the concentration range tested (Fig. 3) . In contrast, C20:5 at 100 and 300 ,uM suppressed S14 mRNA by 80%o and 95%, respectively, when compared to the C18:1 controls. Neither C18:1 nor C20:5 influenced hepatocyte ,B3ac-tin mRNA levels, indicating that the C20:5-mediated suppression of S14 mRNA was not due to generalized toxic effects. These studies show that fatty acids act directly on hepatocytes to inhibit S14 gene expression.
Effects of Fatty Acids on Transfected S14 CAT Gene Expression. To determine whether the inhibitory effect of C20:5 on S14 gene expression was transcriptional, cultured hepatocytes were cotransfected with the S14CAT4.3 and the MLVTRf81 plasmids and treated with T3 (Fig. 4) . In C18:1-treated cells, T3 induced S14CAT activity 2100-fold. In contrast, T3 induced S14CAT activity only 30-fold in C20:5-treated cells, representing a 70% decline in the T3 effect on S14 gene transcription. At 50, 100, and 300 ,uM, C20:5 promoted a 16%, 56%, and 70% dose-dependent decline in S14CAT activity, respectively, with an apparent ED50 of '100 ,uM. Similar effects were seen with arachidonic acid (C20:4w6) on both S14 mRNA and S14CAT activity. These studies show that the inhibitory effect of C20:5 S14CAT activity paralleled the suppression of S14 mRNA, suggesting that C20:5 inhibited endogenous S14 gene expression at the transcriptional level.
The specificity of the C20:5 effect was examined by transfecting hepatocytes with RSVCAT (Fig. 4) . RSVCAT was expressed at high levels after C18:1 treatment and decreased by 9o in C20:5-treated hepatocytes. The lack of any significant effect of C20:5 on RSVCAT-transfected cells indicates that PUFAs (i) are not toxic to hepatocytes at 5300 yM, (ii) do not impede the transcription of the CAT gene driven by the Rous sarcoma virus promoter, and (iii) do not interfere with the analysis of CAT activity. Thus, the inhibitory action of C20:5 on S14 gene transcription was specific.
Lcaliation of PUFA Response Elements (PUFA-REs) by Deletion Analysis. The 5' flanking region of the S14 gene harbors a series ofresponse elements controlled by hormones, nutrients, and tissue-specific factors. These elements are localized within three major DNase I hypersensitive sites (10, 13, (15) (16) (17) . One is located near the 5' end ofthe S14 gene (-290 to +1) and contains several cis-acting elements that function in the organization of the transcriptional preinitiation complex (15, 20) . A second site located between -1400 and -1600 bp contains a series of response elements that are regulated by insulin, carbohydrate, glucocorticoids, retinoic acid, and tissue-specific factors (13) (14) (15) (16) (17) (18) . A third site located between -2500 and -2900 bp contains putative TREs (10, 11) . Hepatocytes were cotransfected with the MLVTR/31 thyroid hormone receptor expression vector and either S14CAT4.3, S14CAT1.6, or S14CAT0.29 fusion genes (Fig.  5 ). Cells were treated with T3 to maximally induce S14CAT activity. Each group was treated with either C18:1 or C20:5 at 300 ,uM. In C18:1-treated cells, T3 induced CAT activity from the S14CAT4.3, S14CAT1.6, and S14CATO.29 genes 100-, 18-, and 3.2-fold, respectively. C20:5 inhibited the T3 stimulation of S14CAT4.3, S14CAT1.6, and S14CATO.29 by 68%, 81%, and 62%, respectively. This pattern of inhibition suggests that the principal target for PUFA control may not be within the two enhancers, at -1.4 to -1.6 kb and -2.5 to -2.9 kb, but within the S14 proximal promoter (+19/-290).
Because the S14 proximal promoter has weak activity in the absence of a strong enhancer, the S14 TRE (-2500/ -2900) was inserted upstream from the proximal promoter (+19 to -290 bp) to assess further the effects of C20:5. T3 induced high levels (>80-fold) of CAT activity in C18:1-treated cells, and C20:5 suppressed the T3-stimulated activity by 65%. These results are similar to the effects of T3 and C20:5 on S14CAT4.3 activity.
To determine whether the S14 TRE was a target for C20:5 control, the S14 TRE was ligated to the TK promoter (Fig. 5) . The TKCAT gene is weakly (<20%) inhibited by C20:5. Addition of the S14 TRE conferred high levels of T3 control to the TKCAT gene (75-fold), and C20:5 suppressed TKCAT activity by <20%, a level of inhibition similar to that seen with the TK promoter alone. Based on these studies, the S14 TRE is not sensitive to C20:5 inhibition. Thus, our studies suggest that elements within the S14 proximal promoter harbor PUFA-RE. Hepatocytes were transfected with S14CAT genes with 5' end points at -4315, -1601, or -290 or with the S14 TRE (-2500/-2900) ligated upstream from the S14 promoter (-290) or upstream from the TK promoter. CAT activity was measured in cells transfected with a TKCAT construct without and with the S14 TRE ligated upstream. Deletion Analysis of the S14 Proximal Promoter. To localize the PUFA-RE within the S14 proximal promoter, a series of promoter deletions were constructed. The promoter fragnents (+19/-290, +19/-220, +19/-121, and +19/-80) were inserted in normal orientation into a plasmid containing the S14 TRE located upstream (5') of the CAT gene (Fig. 6 ). T3 stimulated CAT activity in C18:1-treated cells by 149-fold, while in C20:5-treated cells, T3 stimulated S14CAT activity 56-fold, representing a 64% decline in the T3-mediated induction of S14CAT activity. T3 and C20:5 induced similar effects on S14CAT activity with 5' promoter end points at -220. However, when the promoter was deleted to -121 bp, the degree of C20:5 inhibition declined to 24%o. This plasmid was still highly sensitive to T3 induction (150-fold). Truncating the promoterto -80bp had two effects: (i) a decline in T3 response to only 37-fold and (ii) an abrogation of C20:5 sensitivity. This pattern ofcontrol suggests that the 140-bp region between -80 and -220 bp contains two functional elements. One potentiates T3 activation of S14 gene transcription, and the other is a target for PUFA attenuation of gene transcription.
DISCUSSION
We have used the S14 gene as a model to examine the regulation of lipogenic gene expression by dietary PUFAs. This study confirms and extends previous reports (7) (8) (9) by showing that (i) feeding rats menhaden oil rapidly attenuates (within hours) S14 gene transcription leading to suppression of hepatic S14 mRNA levels, (ii) specific w3 and w6 PUFAs act directly on hepatocytes to suppress S14 mRNA and inhibit S14CAT activity, (iii) C20:5 attenuates T3-stimulated S14 gene transcription, and (iv) w3 fatty acids target cisresponse elements located within the S14 proximal promoter (-80 and -220 bp).
The potent suppressive action of menhaden oil is attributed to the presence of PUFAs, like C20:5c3 and C22:6w3 (21-23, 31, 32) . While treating hepatocytes with C18:1 had little effect on S14 gene expression, both C20:4 and C20:5 suppressed expression of the endogenous gene (S14 mRNA) and the transfected S14CAT genes in a dose-dependent fashion, ED50 ' 100 ,uM (Fig. 3) . PUFA action on hepatic S14 gene expression is direct and does not require extrahepatic mediators (e.g., gut hormones, glucagon, or extrahepatic metabolism of w3 fatty acids).
The in vivo feeding studies illustrate the rapidity of PUFA action on hepatic gene expression. In contrast to white adipose tissue, the liver is an early target for PUFA action. Fatty acid synthase (7-9, 32), malic enzyme (33), steroyl-CoA desaturase (34) , and glucose-6-phosphate dehydrogenase (6, 33) are also inhibited by dietary fat. Finding that transcription of these genes is also rapidly suppressed might suggest that PUFA feeding activates a coordinate regulatory mechanism directed at several genes involved in lipid metabolism. This effect is specific because mRNAs coding for PepCk and /3-actin were not consistently affected by these dietary fats. Understanding this coordinate regulatory mechanism will be important for defining the overall mechanism of PUFA regulation of hepatic lipid synthesis.
The PUFA suppression of S14 gene expression at the transcriptional level suggests a role for PUFA-regulated trans-acting factors. While this study has not identified such factors, we have localized the cis-linked targets of PUFA action to a 140-bp region within the proximal promoter of the S14 gene (i.e., -80 to -220 bp). This region does not contain any known hormone response elements controlling S14 gene transcription. However, this region contains elements that function to initiate S14 gene transcription (15, 20) . These PUFA-REs are regulated by C20:4 and C20:5 and interfere with the T3 control of S14 gene transcription. T3 is a major activator of hepatic S14 gene transcription and regulates S14 gene transcription through TREs located far upstream from the promoter, at -2.5 to -2.9 kb (10, 11, 17) . The S14 TRE was insensitive to PUFA control when inserted upstream from either the TK promoter or the truncated S14 promoter (+19 to -80 bp). Finding that the S14 TRE was not a target for PUFA action suggested that PUFAs may not have generalized effects on other T3-regulated genes.
The S14 proximal promoter (+19 to -220 bp) contains three cis-acting elements that function in the initiation ofgene transcription: (i) a modified TATA box (at -27 bp), (ii) a NF-1/CTF-like binding site (at -48 to -63 bp), and (iii) a cis-acting element (region B, at -88 to -113 bp) that binds tissue-specific factors (20) . The B-region also functions to augment S14 gene transcription (15, 20) . Deletion of the B region results in an >80%o decline in T3 response and a loss of PUFA sensitivity (Fig. 6) . Deletion of the S14 promoter to -120 bp yields a promoter that remains highly sensitive to T3, but is only moderately ('24%) sensitive to PUFA control. This pattern of regulation suggests that factors binding to the B-region function to augment T3 control of transcription. Factors binding upstream from the B-region or within the B-region are targets for C20:5 action. DNase I footprinting and gel shift analysis have not detected specific DNA-protein interaction within the -113 to -220 bp region (data not shown). This is not unexpected if the PUFA-regulated transacting factor is a low abundance protein (e.g., a ligandactivated receptor). While the PUFA-regulated trans-acting factors still remain to be identified, a possible candidate might be the peroxisome proliferator-activated receptor [i.e., PPAR (36) ]. Peroxisomes are induced in liver by fatty acids (37, 38) , and recent studies have reported that some fatty acids activate PPAR (37, 38) . PPAR is a member of the steroid/thyroid/retinoid superfamily of nuclear receptors (36) .
In conclusion, we have shown that w3 fatty acids in menhaden oil can effectively inhibit S14 gene transcription in vivo and in cultured primary hepatocytes. A cis-acting target for PUFA control (i.e., a PUFA-RE) has been localized to the proximal promoter region (-80 to -220 bp) of the S14 gene. The next step will be to identify the trans-acting factors that bind these elements and to determine how PUFA (or their metabolites) regulate these factors.
